Načítá se...
Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy
BACKGROUND: Isotretinoin, a teratogen, is widely used to treat cystic acne. Although the risks of pregnancy during isotretinoin therapy are well recognized, there are doubts about the level of adherence with the pregnancy prevention program in Canada. Our objective was to evaluate the effectiveness...
Uloženo v:
| Vydáno v: | CMAJ |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Joule Inc.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4938682/ https://ncbi.nlm.nih.gov/pubmed/27114489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.151243 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|